- Home
- ELUT vs NTRB Comparison
ELUT vs NTRB Comparison
Compare ELUT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELUT | NTRB |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.3M | 44.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELUT | NTRB |
|---|---|---|
| Price | $1.06 | $3.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 121.4K | 7.9K |
| Earning Date | 05-08-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.77 | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $12,293,000.00 | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $10.83 | $3,394.36 |
| P/E Ratio | $1.22 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $3.42 |
| 52 Week High | $2.60 | $11.68 |
Technical Indicators
Market Signals| Indicator | ELUT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 40.63 |
| Support Level | $1.00 | $3.64 |
| Resistance Level | $1.18 | $4.24 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 45.45 | 20.59 |
Price Performance
Historical ComparisonAbout ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.